行业引领!荣昌生物荣登“中国创新药十年荣耀榜”

荣昌生物
Sep 25

REMEGEN9月24日,2025中国医药决策者峰会在北京召开,会上举行了隆重的“中国创新药十年荣耀榜”发榜仪式,荣昌生物获评“行业引领Biotech公司”,泰它西普(泰爱®)获评“行业引领创新药品”。“中国创新药十年荣耀榜”以医药魔方全产业链数据为依托,榜下设8大荣誉奖项,旨在表彰过去十年取得优异成绩,同时为中国创新药产业升级发挥出推动与引领作用的优秀公司、机构和重大创新成果,为中国创新药产业的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10